We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $8.34B
1-Year Est. Return 46.58%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+46.58%
3 Year Est. Return
+191.6%
5 Year Est. Return
+200.35%
10 Year Est. Return
+3,561.44%
AUM
$5.73B
AUM Growth
+$122M
Cap. Flow
-$305M
Cap. Flow %
-5.31%
Top 10 Hldgs %
36.62%
Holding
266
New
17
Increased
50
Reduced
179
Closed
19

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$54.5M
2
NVO
Novo Nordisk
NVO
+$53.8M
3
ABNB icon
Airbnb
ABNB
+$35.5M
4
BNTX icon
BioNTech
BNTX
+$22.3M
5
NVDA icon
NVIDIA
NVDA
+$16.9M

Sector Composition

Rank Sector Weight
1 Technology 31.88%
2 Consumer Discretionary 24.08%
3 Healthcare 18.93%
4 Industrials 8.2%
5 Communication Services 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
1
Tesla
TSLA
$1.2T
$632M 11.03%
2,383,584
-89,814
-4% -$25.1M
AMZN icon
2
Amazon
AMZN
$2.5T
$252M 4.4%
2,232,826
-165,445
-7% -$20.9M
SWAV
3
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$219M 3.83%
788,874
-179,143
-19% -$45.6M
NET icon
4
Cloudflare
NET
$98.5B
$166M 2.89%
2,998,491
+240,844
+9% +$14.3M
ENPH icon
5
Enphase Energy
ENPH
$4.76B
$162M 2.82%
582,927
-138,118
-19% -$37.3M
CALX icon
6
Calix
CALX
$2.28B
$159M 2.78%
2,604,320
-47,797
-2% -$2.56M
NFLX icon
7
Netflix
NFLX
$306B
$152M 2.66%
6,474,970
-41,410
-0.6% -$920K
ALNY icon
8
Alnylam Pharmaceuticals
ALNY
$38.1B
$133M 2.32%
663,983
-90,592
-12% -$17.3M
PI icon
9
Impinj
PI
$4.19B
$116M 2.03%
1,452,372
-58,448
-4% -$4.87M
INSP icon
10
Inspire Medical Systems
INSP
$1.48B
$107M 1.86%
601,505
-3,876
-0.6% -$779K
POOL icon
11
Pool Corp
POOL
$6.95B
$98.2M 1.71%
308,620
-809
-0.3% -$289K
MDB icon
12
MongoDB
MDB
$26.6B
$96.3M 1.68%
485,126
-57,596
-11% -$16.8M
ISRG icon
13
Intuitive Surgical
ISRG
$127B
$79.7M 1.39%
425,205
-1,399
-0.3% -$300K
DUOL icon
14
Duolingo
DUOL
$6.65B
$77.9M 1.36%
817,544
-10,185
-1% -$991K
HUBS icon
15
HubSpot
HUBS
$12.9B
$77.6M 1.35%
287,264
-24,808
-8% -$7.88M
SHAK icon
16
Shake Shack
SHAK
$2.58B
$75.6M 1.32%
1,681,661
-63,125
-4% -$3.03M
XMTR icon
17
Xometry
XMTR
$4.58B
$72.6M 1.27%
1,277,557
+70,542
+6% +$3.3M
DKS icon
18
Dick's Sporting Goods
DKS
$18.7B
$71.1M 1.24%
679,941
+4,240
+0.6% +$431K
FRPT icon
19
Freshpet
FRPT
$3.06B
$69.5M 1.21%
1,386,932
-221,872
-14% -$10.5M
MELI icon
20
Mercado Libre
MELI
$95.9B
$68.1M 1.19%
82,303
-2,031
-2% -$1.75M
PCOR icon
21
Procore
PCOR
$7.6B
$67.8M 1.18%
1,370,246
+7,306
+0.5% +$393K
GOOGL icon
22
Alphabet (Google) Class A
GOOGL
$4.17T
$66.5M 1.16%
695,681
-45,799
-6% -$5.08M
FND icon
23
Floor & Decor
FND
$6.08B
$63.3M 1.11%
901,544
-1,114
-0.1% -$89.4K
DNLI icon
24
Denali Therapeutics
DNLI
$3.85B
$57.2M 1%
1,863,277
-93,543
-5% -$3.04M
LLY icon
25
Eli Lilly
LLY
$1.09T
$56.6M 0.99%
175,142
+172,139
+5,732% +$54.5M

Similar funds

Gilder Gagnon Howe & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Gilder Gagnon Howe & Co held 266 positions worth $5.73B, up 2.2% from $5.61B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $305M in Q3 2022, closing 19 positions and reducing 179 holdings. Its most notable exit was 1Life Healthcare, an estimated $23.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Novo Nordisk worth $50M.

  • Gilder Gagnon Howe & Co's largest Q3 2022 buy was Novo Nordisk: 1,004,430 shares worth $50M.
  • Gilder Gagnon Howe & Co added most to Eli Lilly in Q3 2022, an estimated $54.5M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2022 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $45.6M.
  • Gilder Gagnon Howe & Co fully exited 1Life Healthcare in Q3 2022, selling an estimated $23.4M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 37% of its $5.73B portfolio in Q3 2022.
  • Gilder Gagnon Howe & Co opened 17 new positions and closed 19 in Q3 2022.
  • Gilder Gagnon Howe & Co's portfolio value rose 2.2% quarter-over-quarter to $5.73B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2022, filed 14 Nov 2022.